{"id":987788647,"date":"2025-09-12T08:47:29","date_gmt":"2025-09-12T07:47:29","guid":{"rendered":"https:\/\/p4h.world\/?post_type=documents&#038;p=987788647"},"modified":"2025-10-21T09:21:13","modified_gmt":"2025-10-21T08:21:13","slug":"pourquoi-les-medicaments-echouent-ils-a-levaluation-des-technologies-de-la-sante-une-analyse-comparative-des-rejets-devaluation-des-technologies-de-la-sante-dans-sept-pays-de-locde","status":"publish","type":"documents","link":"https:\/\/p4h.world\/fr\/documents\/pourquoi-les-medicaments-echouent-ils-a-levaluation-des-technologies-de-la-sante-une-analyse-comparative-des-rejets-devaluation-des-technologies-de-la-sante-dans-sept-pays-de-locde\/","title":{"rendered":"Pourquoi les m\u00e9dicaments \u00e9chouent-ils \u00e0 l&#8217;\u00e9valuation des technologies de la sant\u00e9 : une analyse comparative des rejets d&#8217;\u00e9valuation des technologies de la sant\u00e9 dans sept pays de l&#8217;OCDE"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; admin_label=&#8221;!!! PLEASE DO NOT EDIT !!!&#8221; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row admin_label=&#8221;! !! N&#039;\u00c9DITEZ PAS ! !! &#8221; _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_text admin_label=&#8221;TO BE EDITED &#8211; TEXT &#8211; Click on the WHEEL icon to open the text-area where you can type your text. Add a paragraph to introduce the Document&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p data-start=\"0\" data-end=\"630\">Dans leur article publi\u00e9 dans <a href=\"https:\/\/www.cambridge.org\/core\/journals\/health-economics-policy-and-law\">Health Economics, Policy and Law<\/a> par Cambridge University Press, Filippos Papadopoulos, Erica Visintin, Ilias Kyriopoulos et Panos Kanavos \u00e9tudient les raisons pour lesquelles certains m\u00e9dicaments \u00e9chouent aux <a href=\"https:\/\/www.who.int\/health-topics\/health-technology-assessment\">\u00e9valuations des technologies de la sant\u00e9<\/a> (ETS) dans sept <a href=\"https:\/\/www.oecd.org\/en\/about\/members-partners.html\">pays de l&#8217;OCDE.<\/a> Contrairement \u00e0 la plupart des recherches existantes, qui se concentrent sur les facteurs favorisant les r\u00e9sultats positifs des ETS, cette \u00e9tude fournit une rare analyse comparative des rejets d&#8217;ETS. S&#8217;appuyant sur un ensemble de donn\u00e9es de 1 405 rapports d&#8217;ETS entre 2009 et 2020, les auteurs \u00e9tudient comment les facteurs r\u00e9glementaires, cliniques et \u00e9conomiques contribuent \u00e0 la probabilit\u00e9 qu&#8217;un m\u00e9dicament soit rejet\u00e9.  <\/p>\n<p data-start=\"632\" data-end=\"1075\" data-is-last-node=\"\" data-is-only-node=\"\">Leurs conclusions r\u00e9v\u00e8lent que <strong>12,9 % des demandes d&#8217;ETS ont \u00e9t\u00e9 rejet\u00e9es<\/strong>, avec des taux particuli\u00e8rement \u00e9lev\u00e9s pour les m\u00e9dicaments anticanc\u00e9reux et les m\u00e9dicaments orphelins, ainsi que pour ceux soutenus par des preuves de faible qualit\u00e9 ou marqu\u00e9s par l&#8217;incertitude des mod\u00e8les de co\u00fbt-efficacit\u00e9. Les auteurs identifient \u00e9galement des diff\u00e9rences syst\u00e9matiques entre les agences nationales d&#8217;ETS, soulignant la n\u00e9cessit\u00e9 d&#8217;une plus grande collaboration transfrontali\u00e8re, d&#8217;une am\u00e9lioration des normes en mati\u00e8re de donn\u00e9es probantes et de pratiques d&#8217;\u00e9valuation plus coh\u00e9rentes. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dans leur article publi\u00e9 dans Health Economics, Policy and Law par Cambridge University Press, Filippos Papadopoulos, Erica Visintin, Ilias Kyriopoulos et Panos Kanavos \u00e9tudient les raisons pour lesquelles certains m\u00e9dicaments \u00e9chouent aux \u00e9valuations des technologies de la sant\u00e9 (ETS) dans sept pays de l&#8217;OCDE. Contrairement \u00e0 la plupart des recherches existantes, qui se concentrent sur&#8230;<\/p>\n","protected":false},"author":559,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":""},"categories":[],"tags":[3058,3027],"document_type":[2672],"acf":[],"_links":{"self":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/documents\/987788647"}],"collection":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/documents"}],"about":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/types\/documents"}],"author":[{"embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/users\/559"}],"replies":[{"embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/comments?post=987788647"}],"version-history":[{"count":4,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/documents\/987788647\/revisions"}],"predecessor-version":[{"id":987788662,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/documents\/987788647\/revisions\/987788662"}],"wp:attachment":[{"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/media?parent=987788647"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/categories?post=987788647"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/tags?post=987788647"},{"taxonomy":"document_type","embeddable":true,"href":"https:\/\/p4h.world\/fr\/wp-json\/wp\/v2\/document_type?post=987788647"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}